Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A
Authors:
- Edward F. EllerbeckEEEdward F. Ellerbeck
- John A. LewisJLJohn A. Lewis
- David NalinDNDavid Nalin
- Kenneth GershmanKGKenneth Gershman
- William J. MillerWMWilliam J. Miller
- Marcy E. ArmstrongMAMarcy E. Armstrong
- Joseph P. DavideJDJoseph P. Davide
- Audrey E. RhoadARAudrey E. Rhoad
- Brenda McGuireBMBrenda McGuire
- Gary CalandraGCGary Calandra
- Philip J. ProvostPPPhilip J. Provost
- Karen MidthunKMKaren Midthun
Open Access
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A Simple Antigen-Reduction Assay for the Measurement of Neutralizing Antibodies to Hepatitis A VirusThe Journal of Infectious Diseases, 1991
- Characteristics of inactivated hepatitis A vaccine prepared from virus propagated in heteroploid continuous monkey cell lineVaccine, 1990
- Simultaneous Vaccination for Hepatitis A and BThe Journal of Infectious Diseases, 1990
- IMMUNOGENICITY OF A KILLED HEPATITIS A VACCINE IN SERONEGATIVE VOLUNTEERSThe Lancet, 1989
- Primary Study of Attenuated Live Hepatitis A Vaccine (H2 Strain) in HumansThe Journal of Infectious Diseases, 1989
- Studies of Prototype Live Hepatitis A Virus Vaccines in Primate ModelsThe Journal of Infectious Diseases, 1988
- New Findings in Live, Attenuated Hepatitis A Vaccine DevelopmentJournal of Medical Virology, 1986
- An inactivated hepatitis A viral vaccine of cell culture originJournal of Medical Virology, 1986
- Preparation of a Prototype Inactivated Hepatitis A Virus Vaccine from Infected Cell CulturesThe Journal of Infectious Diseases, 1986
- Type A Viral HepatitisNew England Journal of Medicine, 1985